nitrilotriacetic acid has been researched along with Mast-Cell Sarcoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altin, JG; Parish, CR; van Broekhoven, CL; Vassiliou, G | 1 |
1 other study(ies) available for nitrilotriacetic acid and Mast-Cell Sarcoma
Article | Year |
---|---|
Engrafting costimulator molecules onto tumor cell surfaces with chelator lipids: a potentially convenient approach in cancer vaccine development.
Topics: Amines; Animals; B7-1 Antigen; Cancer Vaccines; CD40 Antigens; Cell Division; Cell Membrane; Chelating Agents; Cytotoxicity, Immunologic; Female; Histidine; Lymphocyte Activation; Male; Mast-Cell Sarcoma; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microscopy, Confocal; Nitrilotriacetic Acid; Protein Binding; T-Lymphocytes; Tumor Cells, Cultured | 2000 |